You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced a range of strategic initiatives to accelerate the delivery of innovative biologics and targeted medicines to patients in China, the company’s second largest market globally and a key growth platforAlready a subscriber Login You have read all…
The winner of the Start-up Slam: Sweden, a pitching competition, taking place at BIO-Europe Spring in Stockholm for the first time, was QureTech Bio AB, a start-up developing first line drugs to combat antibiotic resistance and infectious diseases. This session at the event was co-sponsored by KaAlready a subscriber Login…
Swedish Oasmia Pharmaceutical has submitted an application for marketing approval of Doxophos for Russia and the Commonwealth of the Independent States (CIS). The company expects market approval of Doxophos by the end of 2016. Doxophos is a hybrid and novel nanoparticle formulation of one of the Already a subscriber Login…
Novo Nordisk has announced the European Medicines Agency marketing approval of the mylife YpsoPump insulin pump for use with prefilled pump cartridge NovoRapid PumpCart. The approval is a key milestone for the collaboration between Novo Nordisk and Ypsomed and their goal to deliver innovative cAlready a subscriber Login You have…
